Restructuring
GTX
May 20
▲ +0.60
Garrett Motion Inc. executed Amendment No. 2 to its credit agreement on May 18, 2026, decreasing applicable interest rates on existing term loans and revolving credit facilities. T…
Other
XPEL
May 20
▲ +0.50
Harvest Ventures Holding Company, a XPEL subsidiary, entered into a loan agreement with PNC Bank for $44.8 million to purchase property on North PanAm Expressway in San Antonio, Te…
Earnings
LOW
May 20
▲ +0.65
Lowe's reported Q1 2026 diluted EPS of $2.90 with comparable sales up 0.6%, driven by strong spring execution and online growth of 15.5%. The company affirmed its full-year 2026 ou…
Earnings
SDEV
May 20
▲ +0.65
Stablecoin Development Corporation reported Q1 2026 GAAP net income of $552.4 million, primarily from non-cash warrant-related gains of approximately $535 million, while operating …
Leadership
WEN
May 20
▲ +0.65
Wendy's Board of Directors appointed Robert D. Wright as President and Chief Executive Officer, effective May 21, 2026, with prior experience including CEO roles at Potbelly Corpor…
Earnings
PGR
May 20
▲ +0.65
Progressive Corporation reported April 2026 results showing net income of $1.087 billion, a 10% increase from $986 million in April 2025, with net premiums written growing 6% to $7…
Regulatory
CNMD
May 20
— 0.00
CONMED Corporation amended and restated its bylaws to allow stockholder meetings via remote communication and establishes 25% ownership threshold for stockholder-requested special …
Other
LSBK
May 20
— 0.00
Lake Shore Bancorp, Inc. is conducting its annual shareholders meeting scheduled for May 2026 to elect directors, vote on executive compensation, and ratify its independent account…
Offering
CB
May 20
— 0.00
Chubb Ltd and its subsidiary Chubb INA Holdings LLC entered into an underwriting agreement dated May 18, 2026 to issue senior and subordinated debt securities guaranteed by the par…
Offering
DUKR
May 20
▲ +0.75
Duke Robotics reported Q1 2026 financial results and announced expansion of its Israel Electric Corporation contract expected to generate over $1M in 2026 revenue, plus the launch …
Offering
AMASS
May 20
— 0.00
AMASS Brands Inc's board approved a Certificate of Designation for Series C Convertible Preferred Stock on March 17, 2026, establishing 35,000 shares with conversion rights. The fi…
Regulatory
TELO
May 20
▲ +0.75
Telomir Pharmaceuticals announced peer-reviewed publication of preclinical data demonstrating that Telomir-Zn produced dose-dependent survival improvements and reduced hepatic copp…
Earnings
TGT
May 20
▲ +0.75
Target reported Q1 2026 EPS of $1.71, beating expectations with 6.7% net sales growth and 4.4% comparable traffic growth across all merchandise categories. The company raised its f…
Leadership
CAL
May 20
▲ +0.75
Caleres announced Dan Karpel's permanent appointment as CFO after serving as interim CFO since January 2026, bringing 30 years of finance experience. The company raised Q1 earnings…
Offering
AKAM
May 20
▲ +0.50
Akamai Technologies priced $1.5B of 0% convertible senior notes due 2030 and $1.5B due 2032, with a $500M greenshoe option. The offering was upsized from the originally announced $…
Other
COFS
May 20
— 0.00
ChoiceOne Financial Services Inc. is holding its 39th Annual Shareholder Meeting with agenda items including director elections, executive compensation advisory vote, and auditor r…
M&A
SLUNA
May 20
▲ +0.50
Soluna Digital Inc. is purchasing 11 million membership interests from Navitas West Texas Investments SPV, LLC for $8.77 million, gaining 100% ownership of Soluna DV ComputeCo. The…
Offering
AEP
May 20
▲ +0.50
Appalachian Power Recovery Funding LLC issued $1.375 billion in senior secured bonds backed by securitized asset cost property approved by Virginia regulators. The offering provide…
Earnings
ROIV
May 20
▲ +0.75
Roivant reported strong cash position of $4.3 billion and progress across pipeline including IMVT-1402 showing positive rheumatoid arthritis data, brepocitinib Breakthrough Therapy…
Regulatory
IMVT
May 20
▲ +0.75
Immunovant announced positive Week 16 results from its IMVT-1402 trial in difficult-to-treat rheumatoid arthritis, with response rates of 72.7% ACR20, 54.5% ACR50, and 35.8% ACR70.…